Arrowstreet Capital’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.51M | Sell |
523,967
-566,457
| -52% | -$7.61M | ﹤0.01% | 1078 |
|
|
2025
Q4 | $13.7M | Sell |
1,090,424
-207,338
| -16% | -$2.37M | 0.01% | 836 |
|
|
2025
Q3 | $13M | Sell |
1,297,762
-399,463
| -24% | -$3.59M | 0.01% | 874 |
|
|
2025
Q2 | $13.7M | Sell |
1,697,225
-96,228
| -5% | -$725K | 0.01% | 807 |
|
|
2025
Q1 | $15M | Buy |
1,793,453
+252,395
| +16% | +$2.11M | 0.01% | 683 |
|
|
2024
Q4 | $12.2M | Sell |
1,541,058
-527,921
| -26% | -$4.43M | 0.01% | 764 |
|
|
2024
Q3 | $17.2M | Buy |
2,068,979
+1,269,641
| +159% | +$9.93M | 0.01% | 577 |
|
|
2024
Q2 | $5.08M | Buy |
799,338
+167,430
| +26% | +$1.06M | ﹤0.01% | 836 |
|
|
2024
Q1 | $3.83M | Buy |
631,908
+420,234
| +199% | +$2.37M | ﹤0.01% | 969 |
|
|
2023
Q4 | $1.28M | Sell |
211,674
-590,914
| -74% | -$2.63M | ﹤0.01% | 1057 |
|
|
2023
Q3 | $3.39M | Sell |
802,588
-110,386
| -12% | -$412K | ﹤0.01% | 741 |
|
|
2023
Q2 | $2.83M | Buy |
912,974
+231,957
| +34% | +$494K | ﹤0.01% | 750 |
|
|
2023
Q1 | $947K | Buy |
681,017
+183,543
| +37% | +$365K | ﹤0.01% | 1077 |
|
|
2022
Q4 | $990K | Buy |
+497,474
| New | +$1.12M | ﹤0.01% | 1029 |
|
|
2022
Q2 | – | Sell |
-349,320
| Closed | -$1.46M | – | 1215 |
|
|
2022
Q1 | $1.46M | Buy |
349,320
+146,754
| +72% | +$650K | ﹤0.01% | 871 |
|
|
2021
Q4 | $970K | Buy |
202,566
+111,276
| +122% | +$555K | ﹤0.01% | 1167 |
|
|
2021
Q3 | $487K | Sell |
91,290
-157,870
| -63% | -$795K | ﹤0.01% | 1422 |
|
|
2021
Q2 | $1.28M | Sell |
249,160
-262,592
| -51% | -$1.49M | ﹤0.01% | 1471 |
|
|
2021
Q1 | $3.44M | Buy |
+511,752
| New | +$2.84M | ﹤0.01% | 1336 |
|
|
2020
Q4 | – | Sell |
-114,213
| Closed | -$443K | – | 2267 |
|
|
2020
Q3 | $443K | Sell |
114,213
-1,174,869
| -91% | -$5.02M | ﹤0.01% | 2050 |
|
|
2020
Q2 | $6.14M | Buy |
1,289,082
+1,089,819
| +547% | +$4.49M | 0.01% | 971 |
|
|
2020
Q1 | $693K | Buy |
199,263
+5,527
| +3% | +$23.4K | ﹤0.01% | 1435 |
|
|
2019
Q4 | $934K | Buy |
+193,736
| New | +$673K | ﹤0.01% | 1353 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
